Company Profile: 23andMe

Company Profile: 23andMe

Summary

23andMe is a personal genomics and biotechnology company that leverages machine learning technology to provide DNA analysis services. It also offers web-based interactive tools to individuals, helping them understand their own genetics information.

Scope

The report provides information and insights into 23andMe, including -
- Overview of the company and its product offering
- Detailed insight into its business operation, technology, revenue model, geographical presence and business model
- Information on partnerships, funding and awards it received
- Biography of top management.

Reasons to buy

- Gain insights into 23andMes business operations.
- Gain insights into funding and partnerships.
- Gain understanding about its technology focus and success factors.

Company Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix

2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850

USD 1850 View Report

2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850

USD 1850 View Report

2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Kuwait Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850

USD 1850 View Report

2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Kazakhstan Transfusion Diagnostics Market Assessment--Immunohematology and NAT Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 1850

USD 1850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available